Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?

Applied Microbiology and Biotechnology

Volumn 99, Issue 16, 2015, Pages 6563-6570

  Palma, Mariana L ^a,b   Zamith Miranda, Daniel ^c   Martins, Flaviano S ^d   Bozza, Fernando A ^e   Nimrichter, Leonardo ^c   Montero Lomeli, Mônica ^c   Marques, Ernesto T A ^b,f   Douradinha, Bruno ^b,g  

^a Laboratório de Dermatologia e Imunodeficiências   (Brazil)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e Funda??o Oswaldo Cruz   (Brazil)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g Fondazione RiMED   (Italy)

Author keywords

Expression of heterologous proteins; Mechanisms of action; Probiotics; Saccharomyces cerevisiae; Saccharomyces cerevisiae var boulardii

Indexed keywords

ANIMALS; DISEASE CONTROL; DISEASES; PROTEINS; VALUE ENGINEERING;

EXPRESSION OF HETEROLOGOUS PROTEINS; GASTROINTESTINAL TRACT; HETEROLOGOUS PROTEINS; IMMUNOMODULATORY EFFECTS; INFLAMMATORY BOWEL DISEASE; PROBIOTICS; SACCHAROMYCES CEREVISIAE STRAINS; YEAST SACCHAROMYCES CEREVISIAE;

YEAST;

PROBIOTIC AGENT; RECOMBINANT PROTEIN; SECRETORY IMMUNOGLOBULIN;

DISEASE CONTROL; GASTROENTERITIS; GENE EXPRESSION; HEALTH CARE; PROBIOTICS; PROTEIN; SECRETION; YEAST;

FUNGAL STRAIN; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC TRAIT; HETEROLOGOUS EXPRESSION; IMMUNOMODULATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; ANIMAL; BIOLOGICAL THERAPY; CELL ADHESION; GASTROINTESTINAL DISEASES; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS);

ANIMALIA; SACCHAROMYCES CEREVISIAE;

ANIMALS; BIOLOGICAL THERAPY; CELL ADHESION; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULIN A, SECRETORY; PROBIOTICS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 84937842255     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6776-x     Document Type: Review

References (66)

1. Ardiani A, Higgins JP, Hodge JW (2010) Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res 10:1060–1069
2. Batista TM, Marques ETA, Franco GR, Douradinha B (2014) Draft genome sequence of the probiotic yeast Saccharomyces cerevisiae var boulardii strain ATCC MYA-796. Genome Announc 2:e01345–14
3. Brandão RL, Castro IM, Bambirra EA, Amaral C, Fietto LG, Tropia MJM, José M, Dos Santos RG, Gomes NCM, Nicoli R, Amaral SC, Jose M (1998) Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Env Microbiol 64:564–568
4. Buts J-P, De Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51:1485–1492. doi:10.1007/s10620-005-9016-x
5. Byrd J, Bresalier R (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77–99
6. Cummins J, Ho M-W (2005) Genetically modified probiotics should be banned. Microb Ecol Heal Dis 17:66–68. doi:10.1080/08910600510044480
7. Czerucka D, Piche T, Rampal P (2007) Review article: yeast as probiotics—Saccharomyces boulardii. Aliment Pharmacol Ther 26:767–778
8. Da Silva NA, Srikrishnan S (2012) Introduction and expression of genes for metabolic engineering applications in Saccharomyces cerevisiae. FEMS Yeast Res 12:197–214
9. Dalmasso G, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157:456–465. doi:10.1016/j.resmic.2005.11.007
10. Diosma G, Romanin DE, Rey-Burusco MF, Londero A, Garrote GL (2014) Yeasts from kefir grains: isolation, identification, and probiotic characterization. World J Microbiol Biotechnol 30:43–53. doi:10.1007/s11274-013-1419-9
11. Douradinha B, Reis VCB, Rogers MB, Torres FAG, Evans JD, Marques ETA (2014) Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii. Bioengineered 5:1–9
12. Edwards-Ingram LC, Gent ME, Hoyle DC, Hayes A, Stateva LI, Oliver SG (2004) Comparative genomic hybridization provides new insights into the molecular taxonomy of the Saccharomyces sensu stricto complex. Genome Res 14:1043–1051
13. Edwards-Ingram L, Gitsham P, Burton N, Warhurst G, Clarke I, Hoyle D, Oliver SG, Stateva L (2007) Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Env Microbiol 73:2458–2467
14. Feizizadeh S, Salehi-Abargouei A, Akbari V (2014) Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 134:e176–e191. doi:10.1542/peds.2013-3950
15. Ferraretto LF, Shaver RD, Bertics SJ (2012) Effect of dietary supplementation with live-cell yeast at two dosages on lactation performance, ruminal fermentation, and total-tract nutrient digestibility in dairy cows. J Dairy Sci 95:4017–4028. doi:10.3168/jds.2011-5190
16. Fietto JLR, Araújo RS, Valadão FN, Fietto LG, Brandão RL, Neves MJ, Gomes FCO, Nicoli JR, Castro IM (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 621:615–621
17. Foligné B, Dewulf J, Vandekerckove P, Pignède G, Pot B (2010) Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World J Gastroenterol 16:2134. doi:10.3748/wjg.v16.i17.2134
18. Gedek BR (1999) Adherence of Escherichia coli serogroup 0 157 and the Salmonella Typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42:261–264
19. Generoso SV, Viana M, Santos R, Martins FS, Machado JAN, Arantes RME, Nicoli JR, Correia MITD, Cardoso VN (2010) Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192:477–484
20. Girardin M, Seidman EG (2011) Indications for the use of probiotics in gastrointestinal diseases. Dig Dis 29:574–587. doi:10.1159/000332980
21. Goldstein AL, McCusker JH (1999) Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15:1541–1553
22. Gottardi R, Douradinha B (2013) Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer. J Nanobiotechnol 11:30. doi:10.1186/1477-3155-11-30
23. Gritz L, Davies J, Biogen SA, Acacias R (1983) Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25:179–188
24. Hamedi H, Misaghi A, Modarressi MH, Salehi TZ, Khorasanizadeh D, Khalaj V (2013) Generation of a uracil auxotroph strain of the probiotic yeast Saccharomyces boulardii as a host for the recombinant protein production. Avicenna J Med Biotechnol 5:29–34
25. Hudson LE, Fasken MB, McDermott CD, McBride SM, Kuiper EG, Guiliano DB, Corbett AH, Lamb TJ (2014) Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii. PLoS One 9, e112660
26. Kawai S, Hashimoto W, Murata K (2010) Transformation of Saccharomyces cerevisiae and other fungi: methods and possible underlying mechanism. Bioeng Bugs 1:395–403
27. Khatri I, Akhtar A, Kaur K, Tomar R, Prasad GS, Ramya TNC, Subramanian S (2013) Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii. Gut Pathog 5:30. doi:10.1186/1757-4749-5-30
28. Kourelis A, Kotzamanidis C, Litopoulou-Tzanetaki E, Papaconstantinou J, Tzanetakis N, Yiangou M (2010) Immunostimulatory activity of potential probiotic yeast strains in the dorsal air pouch system and the gut mucosa. J Appl Microbiol 109:260–271. doi:10.1111/j.1365-2672.2009.04651.x
29. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274
30. Latorre-García L, Adam AC, Polaina J (2008) Overexpression of the glucoamylase-encoding STA1 gene of Saccharomyces cerevisiae var. diastaticus in laboratory and industrial strains of Saccharomyces. World J Microbiol Biotechnol 24:2957–2963
31. Martins FS, Nardi RMD, Arantes RME, Rosa CA, Neves MJ, Nicoli JR (2005) Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 51:83–92
32. Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, Arantes RME, Nardi RMD, Neves MJ, Nicoli JR (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56:352–359
33. Martins FS, Dalmasso G, Arantes RME, Doye A, Lemichez E, Lagadec P, Imbert V, Peyron J-F, Rampal P, Nicoli JR, Czerucka D (2010) Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS One 5, e8925
34. Martins FS, Elian SDA, Vieira AT, Tiago FCP, Martins AKS, Silva FCP, Souza ELS, Sousa LP, Araújo HRC, Pimenta PF, Bonjardim CA, Arantes RME, Teixeira MM, Nicoli JR (2011) Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever. Int J Med Microbiol 301:359–364
35. Martins FS, Vieira AT, Elian SDA, Arantes RME, Tiago FCP, Sousa LP, Araújo HRC, Pimenta PF, Bonjardim CA, Nicoli JR, Teixeira MM (2013) Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes Infect 15:270–279
36. Mathur S, Singh R (2005) Antibiotic resistance in food lactic acid bacteria—a review. Int J Food Microbiol 105:281–295. doi:10.1016/j.ijfoodmicro.2005.03.008
37. McFarland LV (2010) Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16:2202. doi:10.3748/wjg.v16.i18.2202
38. Michael S, Keubler LM, Smoczek A, Meier M, Gunzer F, Pöhlmann C, Krause-Buchholz U, Hedrich H-J, Bleich A (2013) Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging. Inflamm Bowel Dis 19:185–193
39. Mumy KL, Chen X, Kelly CP, McCormick BA (2008) Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am J Physiol Gastrointest Liver Physiol 294:G599–G609. doi:10.1152/ajpgi.00391.2007
40. O’Horo JC, Jindai K, Kunzer B, Safdar N (2014) Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 42:43–59. doi:10.1007/s15010-013-0496-x
41. Oliveira AF, Cardoso SA, Almeida FBDR, de Oliveira LL, Pitondo-Silva A, Soares SG, Hanna ES (2012) Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice. Microbiol Immunol 56:513–522
42. Owen JL, Sahay B, Mohamadzadeh M (2013) New generation of oral mucosal vaccines targeting dendritic cells. Curr Opin Chem Biol 17:918–924. doi:10.1016/j.cbpa.2013.06.013
43. Pérez-Sotelo LS, Talavera-Rojas M, Monroy-Salazar HG, Cuarón-Ibargüengoytia JA, Montes R, Jiménez DO, Vázquez-Chagoyán JC (2005) In vitro evaluation of the binding capacity of Saccharomyces cerevisiae Sc47 to adhere to the wall of Salmonella spp. Rev Latinoam Microbiol 47:70–75
44. Perricone M, Bevilacqua A, Corbo MR, Sinigaglia M (2014) Technological characterization and probiotic traits of yeasts isolated from Altamura sourdough to select promising microorganisms as functional starter cultures for cereal-based products. Food Microbiol 38:26–35. doi:10.1016/j.fm.2013.08.006
45. Plaza-Diaz J, Gomez-Llorente C, Fontana L, Gil A (2014) Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. World J Gastroenterol 20:15632–15649. doi:10.3748/wjg.v20.i42.15632
46. Pohlmann C, Thomas M, Forster S, Brandt M, Hartmann M, Bleich A, Gunzer F (2013) Use of engineered intestinal microorganisms as in situ cytokine delivery system. Bioengineered 4:1–8
47. Pothoulakis C (2009) Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther 30:826–833. doi:10.1111/j.1365-2036.2009.04102.x
48. Reis VCB, Nicola AM, de Souza Oliveira Neto O, Batista VDF, de Moraes LMP, Torres FAG (2012) Genetic characterization and construction of an auxotrophic strain of Saccharomyces cerevisiae JP1, a Brazilian industrial yeast strain for bioethanol production. J Ind Microbiol Biotechnol 39:1673–1683
49. Rodrigues ACP, Cara DC, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89:404–414
50. Romanin D, Serradell M, González Maciel D, Lausada N, Garrote GL, Rumbo M (2010) Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir. Int J Food Microbiol 140:102–108. doi:10.1016/j.ijfoodmicro.2010.04.014
51. Salyers AA, Gupta A, Wang Y (2004) Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12:412–416. doi:10.1016/j.tim.2004.07.004
52. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE (2006) Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6:374–382. doi:10.1016/S1473-3099(06)70495-9
53. Schneiter R (2004) Genetics, molecular and cell biology of yeast. Université di Fribourg Suisse, Fribourg
54. Sivignon A, de Vallée A, Barnich N, Denizot J, Darcha C, Pignède G, Vandekerckove P, Darfeuille-Michaud A (2015) Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn’s disease. Inflamm Bowel Dis 21:276–286
55. Smith IM, Christensen JE, Arneborg N, Jespersen L (2014) Yeast modulation of human dendritic cell cytokine secretion: an in vitro study. PloS Onene 9, e96595. doi:10.1371/journal.pone.0096595
56. Soares RL (2014) Irritable bowel syndrome: a clinical review. World J Gastroenterol 20:12144. doi:10.3748/wjg.v20.i34.12144
57. Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, Pothoulakis C, Kelly CP (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343:69–76. doi:10.1016/j.bbrc.2006.02.080
58. Temmerman R, Pot B, Huys G, Swings J (2003) Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 81:1–10
59. Tiago FCP, Martins FS, Souza ELS, Pimenta PFP, Araujo HRC, Castro IM, Brandão RL, Nicoli JR (2012) Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J Med Microbiol 61:1194–1207
60. Van der Aa Kühle A, Skovgaard K, Jespersen L (2005) In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol 101:29–39. doi:10.1016/j.ijfoodmicro.2004.10.039
61. Vieira AT, Teixeira MM, Martins FS (2013) The role of probiotics and prebiotics in inducing gut immunity. Front Immunol 4:445. doi:10.3389/fimmu.2013.00445
62. Wang T, Sun H, Zhang J, Liu Q, Wang L, Chen P, Wang F, Li H, Xiao Y, Zhao X (2014) The establishment of Saccharomyces boulardii surface display system using a single expression vector. Fungal Genet Biol 64:1–10
63. Whelan K (2007) Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics. Proc Nutr Soc 66:299–306. doi:10.1017/S0029665107005551
64. Wu X, Vallance BA, Boyer L, Bergstrom KSB, Walker J, Madsen K, O’Kusky JR, Buchan AM, Jacobson K (2008) Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 294:G295–G306
65. Zanello G, Berri M, Dupont J, Sizaret P-Y, D’Inca R, Salmon H, Meurens F (2011) Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One 6, e18573. doi:10.1371/journal.pone.0018573
66. Zanello G, Melo S, Berri M, Inca RD, Auclair E, Salmon H (2013) Effects of dietary yeast strains on immunoglobulin in colostrum and milk of sows. Vet Immunol Immunopathol 152:20–27